Register Cart 0

Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back Subscribe

Editorial [Hot Topic: Targeting the Microenvironment in Hematological Malignancies: How to Condition both Stromal and Effector Cells to Overcome Cancer Spreading(Guest Editors: Maria Raffaella Zocchi and Alessandro Poggi)]

Author(s): Maria Raffaella Zocchi and Alessandro Poggi

Volume 18, Issue 34, 2011

Page: [5172 - 5173] Pages: 2

DOI: 10.2174/092986711798184235

Next »

Rights & Permissions Print Cite

Article Metrics

13

Wayfinder Image

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Adverse Effects and Drug Interactions of Biologic Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Adverse Events of Proton Pump Inhibitors: Potential Mechanisms
Current Drug Metabolism

ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy
Current Pharmaceutical Design

Expression and Function of the Leukocyte Integrins in Organ Transplant Rejection
Current Medicinal Chemistry

Current Understanding of the Potential of Proteomics and Metabolomics Approaches in Cancer Chemoresistance: A Focus on Multiple Myeloma
Current Topics in Medicinal Chemistry

Protein Geranylgeranyltransferase Type 1 as a Target in Cancer
Current Cancer Drug Targets

Phosphoproteomics as a Promising Tool for Broadening the Analysis of Clinical Samples and for the Fight Against Cancer Disease
Current Pharmaceutical Analysis

Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry

A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer
Current Cancer Drug Targets

Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept
Current Cancer Drug Targets

Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells
Current Drug Delivery

CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies
Current Cancer Drug Targets

The Rationale of Targeting Neutrophils with Dapsone during Glioblastoma Treatment
Anti-Cancer Agents in Medicinal Chemistry

MicroRNAs in Leukemias: Emerging Diagnostic Tools and Therapeutic Targets
Current Drug Targets

Anti-cancer Immunotoxins, Challenges, and Approaches
Current Pharmaceutical Design

The Molecular Basis of Herpesviruses as Oncolytic Agents
Current Pharmaceutical Biotechnology

Older and New Formulations of Cladribine. Pharmacology and Clinical Efficacy in Hematological Malignancies
Recent Patents on Anti-Cancer Drug Discovery

Histone Modifier Differentially Regulates Gene Expression and Unravels Survival Role of MicroRNA-494 in Jurkat Leukemia
MicroRNA

Towards Cure of CML: Why We Need to Know More About CML Stem Cells?
Current Stem Cell Research & Therapy

Using Nutrigenomics to Evaluate Apoptosis as a Preemptive Target in Cancer Prevention
Current Cancer Drug Targets

© 2024 Bentham Science Publishers | Privacy Policy